methyl N-[(1R)-2-[(2S)-2-[6-[6-[2-[(2S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyridazin-3-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate | 1239652-61-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl N-[(1R)-2-[(2S)-2-[6-[6-[2-[(2S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyridazin-3-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
• CAS: 1239652-61-9
• 化学式: C₄₆H₄₄N₁₀O₆
• 分子量: 832.919
• InChiKey: OUIPRAFPYYWJLK-JPYDVTDNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  62
• 可旋转键数：
  12
• 环数：
  9.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  200
• 氢给体数：
  4
• 氢受体数：
  10

文献信息

• [EN] BIS-BENZIMIDAZOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE BIS-BENZIMIDAZOLE
  申请人：TIBOTEC PHARM LTD

  公开号：WO2011026920A1

  公开（公告）日：2011-03-10

  Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R' have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.

  公式（I）的HCV复制抑制剂，包括立体化学异构体形式以及其盐、水合物、溶剂化物，其中R和R'的含义如本文所定义。本发明还涉及制备所述化合物的过程，包含它们的制药组成物以及它们在HCV治疗中的应用。
• Bis-Benzimidazole Derivatives
  申请人：Vandyck Koen

  公开号：US20120172368A1

  公开（公告）日：2012-07-05

  Inhibitors of HCV replication of formula I including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R′ have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.